The Food and Drug Administration (FDA) has granted 510(k) clearance for Vesalio’s enVast clot retriever, paving the way for ...
US-based Subsense has raised $10m, bringing the brain-computer interface (BCI) developer’s total funding to $27m since it ...
Guardant Health and AI technology firm Trial Library have formed a strategic partnership aimed at improving access to cancer ...
The US Food and Drug Administration (FDA) has cleared Flow Neuroscience’s at-home, non-drug depression treatment, making it ...
Impulse Dynamics has secured over $158m in funding aimed at supporting its commercialisation efforts and progressing its ...
Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two ...
HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis ...
Nitinotes has commenced its US investigational device exemption (IDE) Endoscopic Automated Sleeve Evaluation (EASE) Clinical ...
Roche has secured CE Mark approval for its cobas BV/CV assay to support the diagnosis of infectious causes of vaginitis.
Pulse Biosciences has partnered with The University of Texas MD Anderson Cancer Centre to investigate the use of the nPulse ...
Medline has filed for an initial public offering (IPO) seeking to raise up to $5.37bn, a figure that would leave the medical ...
Aquapass has secured marketing approval in Israel for the AQUAPASS System, intended for patients experiencing fluid overload.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results